VAMP7 and breast carcinoma: Taken together, these results for the first time identified the complete SNARE composition mediating MVB–PM fusion in MCF‐7 human breast cancer cells, and emphasize the potential of VAMP‐7 as a therapeutic target to suppress tumour‐derived exosome secretion, making this a promising strategy for the treatment of breast cancer.